Notification That Annual Report Will Be Submitted Late (nt 10-k)
31 Mars 2021 - 11:25PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SEC File Number 001-35853
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one):
x Form 10-K
¨ Form 20-F
¨ Form 11-K
¨ Form 10-Q
¨ Form N-SAR
For Period Ended: December 31, 2020
¨ Transition Report on Form 10-K
¨ Transition Report on Form 20-F
¨ Transition Report on Form 11-K
¨ Transition Report on Form 10-Q
¨ Transition Report on Form N-SAR
For the Transition Period Ended: _______________
|
|
|
Read Instruction (on
back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall
be construed to imply that the Commission has verified any information contained herein.
|
|
|
|
|
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
|
|
PART I — REGISTRANT INFORMATION
|
Biostage, Inc.
|
|
|
Full Name of Registrant
|
|
|
|
|
|
Harvard Apparatus Regenerative
Technology, Inc.
|
|
|
Former Name if Applicable
|
|
|
|
|
|
84 October Hill Road, Suite 11
|
|
|
Address of Principal Executive Office (Street and Number)
|
|
|
|
|
|
Holliston, MA 01746
|
|
|
City, State and Zip Code
|
|
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check
box if appropriate)
|
x
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
¨
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail the reasons why
Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report thereof, could not be filed within the prescribed time period.
Biostage, Inc. (the "Company")
could not complete the filing of its Annual Report on Form 10-K for the period ended December 31, 2020 due to disruptions
in staffing. This in turn, delayed the Company’s ability to obtain and compile the information required to be included in the Company's
Form 10-K, which delay could not be eliminated by the Company without unreasonable effort and expense. In accordance with Rule 12b-25
of the Securities Exchange Act of 1934, as amended, the Company will file its Form 10-K no later than the fifteenth calendar day following
the prescribed due date.
PART IV — OTHER INFORMATION
|
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|
|
Hong Yu
|
|
774
|
|
233-7300
|
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
|
|
Yes x No ¨
|
|
|
|
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|
|
Yes ¨ No x
|
|
|
|
|
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
Biostage, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its
behalf by the undersigned hereunto duly authorized.
|
Date: March 31, 2021
|
By:
|
/s/ Hong Yu
|
|
|
|
|
Name: Hong Yu
|
|
|
|
|
Title: President
|
|
NYLI Healthy Hearts ETF (AMEX:HART)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
NYLI Healthy Hearts ETF (AMEX:HART)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
